REFANALIN Trademark

Trademark Overview

On Thursday, December 29, 2016, a trademark application was filed for REFANALIN with the United States Patent and Trademark Office. The USPTO has given the REFANALIN trademark a serial number of 87283971. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 24, 2020. This trademark is owned by Angion Biomedica Corp. The REFANALIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for medicinal purposes for use in the treatment of ischemic conditions of the heart, brain, kidney and liver and for fibrosis of the liver, lung and kidney
refanalin

General Information

Serial Number87283971
Word MarkREFANALIN
Filing DateThursday, December 29, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 24, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 23, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for medicinal purposes for use in the treatment of ischemic conditions of the heart, brain, kidney and liver and for fibrosis of the liver, lung and kidney

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 10, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAngion Biomedica Corp
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFort Lee, NJ 07024
Party NameAngion Biomedica Corp
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFort Lee, NJ 07024

Trademark Events

Event DateEvent Description
Monday, August 24, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 24, 2020ABANDONMENT - NO USE STATEMENT FILED
Saturday, February 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 21, 2020EXTENSION 5 GRANTED
Saturday, January 18, 2020EXTENSION 5 FILED
Friday, February 21, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 23, 2020NOTICE OF REVIVAL - E-MAILED
Wednesday, January 22, 2020EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, January 22, 2020PETITION TO REVIVE-GRANTED
Wednesday, January 22, 2020TEAS PETITION TO REVIVE RECEIVED
Tuesday, July 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 5, 2019EXTENSION 4 GRANTED
Friday, July 5, 2019EXTENSION 4 FILED
Friday, July 5, 2019TEAS EXTENSION RECEIVED
Wednesday, January 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 7, 2019EXTENSION 3 GRANTED
Monday, January 7, 2019EXTENSION 3 FILED
Monday, January 7, 2019TEAS EXTENSION RECEIVED
Tuesday, July 3, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 29, 2018EXTENSION 2 GRANTED
Friday, June 29, 2018EXTENSION 2 FILED
Friday, June 29, 2018TEAS EXTENSION RECEIVED
Saturday, December 30, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 28, 2017EXTENSION 1 GRANTED
Thursday, December 28, 2017EXTENSION 1 FILED
Thursday, December 28, 2017TEAS EXTENSION RECEIVED
Tuesday, July 18, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 23, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 23, 2017PUBLISHED FOR OPPOSITION
Wednesday, May 3, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 19, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, April 13, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 13, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 13, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 13, 2017ASSIGNED TO LIE
Wednesday, March 29, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 27, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 27, 2017NON-FINAL ACTION E-MAILED
Monday, March 27, 2017NON-FINAL ACTION WRITTEN
Monday, March 27, 2017ASSIGNED TO EXAMINER
Tuesday, January 10, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, January 2, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

refanalin liver kidney brain fibrosis lung heart conditions medicinal preparations purposes